×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Liminal divesting Prometic to KKR in $100m deal - Bioprocess Insider
BioProcess International
Investment firm KKR is set to acquire Prometic Bioseparations, the chromatography and bioprocessing business of Liminal BioSciences.
2 months ago
Dramatic dilution at Prometic Life Sciences draws ire of shareholders
Financial Post
Toronto Stock Exchange granted the company's application to go ahead without a shareholder vote due to 'financial hardship'
60 months ago
Kedrion Biopharma grows in North America as it completes acquisition of Prometic
PR Newswire
PRNewswire/ -- Kedrion Biopharma, the rapidly growing international biopharmaceuticals company that produces and distributes plasma-derived...
30 months ago
Prometic secures $50M stock sale option to ease cash crunch
Fierce Biotech
Prometic Life Sciences has entered into an agreement to sell up to $50 million in stock over.
65 months ago
IPF Therapy Maker Prometic's Phase 3 Trial Plan Wins FDA Approval
Lung Disease News
The U.S. Food and Drug Administration has approved Prometic Life Sciences' plan for a Phase 3 pivotal trial of its idiopathic pulmonary...
75 months ago
PROMETIC New Tech Harvests Orphan Treatments
Life Science Leader
To understand Prometic's therapeutic in development, some knowledge of its technology platform is essential. The platform is the Plasma Protein...
79 months ago
ProMetic to Acquire Telesta Therapeutics
Genetic Engineering and Biotechnology News
ProMetic Life Sciences plans to acquire Telesta Therapeutics, the companies said today, in a deal the buyer said would help it further...
92 months ago
EX-99.75
SEC.gov
LAVAL, QUEBEC, CANADA – March 28, 2018 – Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic) today announced new clinical data from its ongoing...
53 months ago
Work Stops on Fezagepras, or PBI-4050, as Potential IPF Treatment
Pulmonary Fibrosis News
Liminal BioSciences is stopping clinical work on fezagepras (PBI-4050) to treat IPF based on interim results of a Phase 1 trial in...
35 months ago
ProMetic's PBI-4050 Demonstrates Early Evidence of Efficacy in its Idiopathic Pulmonary Fibrosis ("IPF") Phase 2 ...
Canada Newswire
CNW Telbec/ - ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" or the "Corporation") announced today positive interim...
89 months ago